WhiteOak Capital Quality Equity Fund - Regular (G) - Mutual Fund Analysis | Complete Fund Review with Performance, Portfolio, and Risk Analysis
Comprehensive analysis of WhiteOak Capital Quality Equity Fund - Regular (G) (45379) providing detailed insights into fund performance, portfolio holdings, risk metrics, expense ratios, and investment recommendations.
WhiteOak Capital Quality Equity Fund - Regular (G)
WhiteOak Capital Asset Management Ltd
The objective of the Scheme is to provide long term capital appreciation by constructing a diversified investment portfolio based on the quality factor theme to provide investors with exposure to companies having strong fundamentals and sustainable competitive advantages, i.e., companies which exhibit long term stability as they may lead to more predictable returns, less volatility, strong management and sustainable growth. There is no assurance that the investment objective of the Scheme will be achieved.
Fund Health Radar
A comprehensive at-a-glance view of key mutual fund health indicatorsHover or click any card to view detailed metrics
Performance
Good Returns
Risk
High Risk
Expenses
High Expenses
Portfolio Mix
Equity Focused
Management
New Team
Quality Score
Below Average
WhiteOak Capital Quality Equity Fund - Regular (G) - NAV History (1Y)
Showing 1Y NAV history
Performance across different time periods
Cautious Entry Point
Fund shows concerning indicators. Exercise caution before investing.
Consider waiting for better market conditions or explore alternatives.
Cautious Entry Point
Fund shows concerning indicators. Exercise caution before investing.
Consider waiting for better market conditions or explore alternatives.
Key Factors Analysis
1-Year Returns
Recent performance momentum
Alpha Generation
Outperformance vs benchmark
Equity Exposure
Market exposure level
Long-term Track Record
Historical performance consistency
Risk Assessment
Risk-adjusted returns
Fund Size
Assets under management
Management Stability
Fund manager experience
Cost Efficiency
Fund management costs
Investment Timing Insights
3Y Performance Comparison
This fund has underperformed its benchmark by 34.59% over the 3Y period.
See how your money can grow and compare with popular investment options
Your Investment
Compare With Popular Options
Disclaimer: Returns are illustrative and based on assumed rates. Mutual fund investments are subject to market risk. Please read scheme documents carefully.
Risk Metrics (3 Years)
Risk Level
| Company | Industry | % Assets |
|---|---|---|
| C C I | Debt Others | 7.00% |
| ICICI Bank Ltd | Banks | 5.08% |
| Tata Consultancy Services Ltd | IT - Software | 4.17% |
| HDFC Bank Ltd | Banks | 3.80% |
| Mahindra & Mahindra Ltd | Automobile | 3.58% |
| Bharti Airtel Ltd | Telecom-Service | 3.15% |
| Nexus Select Trust | Infra/ Real Estate Investment Trust | 2.58% |
| Godrej Consumer Products Ltd | FMCG | 2.52% |
| Bharti Airtel Ltd Partly Paidup | Telecom-Service | 2.52% |
| Titan Company Ltd | Diamond, Gems and Jewellery | 2.51% |
Sector Breakdown
Compare against Sectoral / Thematic category average
Performance Summary
This comparison shows how the fund performs relative to the Sectoral / Thematic category average. Positive values indicate outperformance, while negative values show underperformance.
Compare with similar funds in Sectoral / Thematic category
WhiteOak Capital Quality Equity Fund - Regular (G) vs Category Average
Similar Funds Comparison
| Fund Name | NAV | 1M | 3M | 6M |
|---|---|---|---|---|
| Aditya Birla SL MNC Fund - Direct (G) | ₹1531.82 | 1.47% | 4.17% | 20.90% |
| Aditya Birla SL MNC Fund - (G) | ₹1374.21 | 1.41% | 3.98% | 20.48% |
| Nippon India Banking&Financial Services-Dir(G) | ₹705.66 | -1.32% | -2.23% | 13.57% |
| Nippon India Banking&Financial Services-Dir(Bonus) | ₹705.66 | -1.32% | -2.23% | 13.57% |
| Nippon India Banking&Financial Services (G) | ₹644.41 | -1.39% | -2.44% | 13.09% |
| Nippon India Banking&Financial Services (Bonus) | ₹644.41 | -1.39% | -2.44% | 13.09% |
| Nippon India Pharma Fund - Direct (G) | ₹572.40 | -0.43% | 2.59% | 13.30% |
| Nippon India Pharma Fund - Direct (Bonus) | ₹572.40 | -0.43% | 2.59% | 13.30% |
| Franklin India Technology Fund - Direct (G) | ₹570.37 | 2.73% | 3.31% | 7.85% |
| ICICI Pru FMCG Fund - Direct (G) | ₹522.74 | 1.69% | 3.11% | 13.18% |
Category Average Returns
Ramesh Mantri
A seasoned investment professional with over 1 years of experience in equity research and fund management. Known for consistent performance and a disciplined investment approach focused on quality growth stocks.